Event Detail (Archived)

Hep C Seminar—Development of Live Recombinant Flavivirus Vaccines

  • This event already took place in October 2016
  • 305 WRB

Event Details

Speaker(s)
Thomas Monath, M.D., chief scientific officer and chief operations officer, infectious disease division, NewLink Genetics Corporation
Open to
Public
Contact
Glen Santiago
Phone
(212) 327-7009
Sponsor
Glen Santiago
(212) 327-7009
gsantiago@rockefeller.edu

Related News

The value of publishing negative data

Scientific publishing has a bias against negative results and that hurts science, says Tim Fessenden, editor of Life Science Alliance, a publication of Rockefeller University Press. Here’s how journal editors can help.

Researchers identify gene that calms the mind and improves attention in mice

Study demonstrates that the Homer1 gene improves focus by reducing "noise" in the prefrontal cortex, with implications for the study of ADHD and other attention disorders.

Some mammals can hit pause on a pregnancy. Understanding how that happens could help us treat cancer.

New study reveals the molecular brake that lets embryonic stem cells enter suspended animation, while retaining the ability to develop normally—which could shed light on abnormal cell growth in humans.

Related Events

Pre-Seminar Coffee and Cookies

| LOWER LEVEL GREENBERG BUILDING (CRC)

Microscale Biophysics of the Ocean: A Single-Cell Perspective on the Biological Carbon Pump

| CARSON FAMILY AUDITORIUM (CRC)

Liquid Biopsies in Pediatric Solid Tumors

| CARSON FAMILY AUDITORIUM (CRC)